Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease.Show others and affiliations
2005 (English)In: Respir Med, ISSN 0954-6111, Vol. 99, no 12, p. 1511-20Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 99, no 12, p. 1511-20
Keywords [en]
Adrenal Cortex Hormones/therapeutic use, Adrenergic beta-Agonists/*therapeutic use, Adult, Aged, Aged; 80 and over, Analysis of Variance, Comparative Study, Double-Blind Method, Drug Administration Schedule, Drug Therapy; Combination, Ethanolamines/*therapeutic use, Female, Forced Expiratory Volume/drug effects, Humans, Lung/drug effects/physiopathology, Male, Middle Aged, Nebulizers and Vaporizers, Pulmonary Disease; Chronic Obstructive/*drug therapy/physiopathology/psychology, Quality of Life, Research Support; Non-U.S. Gov't, Terbutaline/therapeutic use, Treatment Outcome
Identifiers
URN: urn:nbn:se:uu:diva-83354PubMedID: 16199148OAI: oai:DiVA.org:uu-83354DiVA, id: diva2:111262
2006-11-012006-11-012011-01-12